Cite
Human Epidermal Growth Factor Receptor 2–Mutant Non–Small-Cell Lung Cancer: Continued Progress But Challenges Remain
MLA
Alissa J. Cooper, and Justin F. Gainor. “Human Epidermal Growth Factor Receptor 2–Mutant Non–Small-Cell Lung Cancer: Continued Progress But Challenges Remain.” Journal of Clinical Oncology, vol. 40, Mar. 2022, pp. 693–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3732ded72d6d3e4489258cb070f6c9de&authtype=sso&custid=ns315887.
APA
Alissa J. Cooper, & Justin F. Gainor. (2022). Human Epidermal Growth Factor Receptor 2–Mutant Non–Small-Cell Lung Cancer: Continued Progress But Challenges Remain. Journal of Clinical Oncology, 40, 693–697.
Chicago
Alissa J. Cooper, and Justin F. Gainor. 2022. “Human Epidermal Growth Factor Receptor 2–Mutant Non–Small-Cell Lung Cancer: Continued Progress But Challenges Remain.” Journal of Clinical Oncology 40 (March): 693–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3732ded72d6d3e4489258cb070f6c9de&authtype=sso&custid=ns315887.